A Radioactivity-mass Spectrometry Calibration Method Coupled with Biosynthesis to Generate a Metabolite Standard for...

In early stages of drug development, the absence of authentic metabolite standards often results in semi-quantitative measurements of metabolite formation in reaction phenotyping studies using mass spectrometry (MS), leading to inaccuracies in the determination of enzyme kinetic parameters, such as the Michaelis constant (K_m). Moreover, it is impossible to ascertain the maximum rate of enzyme-catalyzed reactions (k_cat or V_max). The use of radiolabeled parent compounds can circumvent this problem. However, radiometric detection exhibits significantly lower sensitivity compared to MS. To address these challenges, we have developed a stepwise approach that leverages biosynthesized radiolabeled and non-radiolabeled metabolites as standards, enabling accurate determination of K_m, k_cat or V_max without the need for authentic metabolite standards. This approach, using the carbon-14 [¹⁴C] labeled metabolite to calibrate the unlabeled metabolite (¹⁴C calibration method), combines radiometric with LC-MS/MS detection to generate both [¹⁴C]-labeled and unlabeled metabolite standard curves to ensure that the sample concentrations measured are accurately quantitated. Two case studies were presented to demonstrate the utility of this method. We first compared the accuracy of the ¹⁴C calibration method to the use of authentic standards for quantitating imipramine metabolites. Next, we biosynthesized and quantitated the metabolites of BI 894416 using ¹⁴C calibration method and evaluated the enzyme kinetics of metabolite formation. The K_m values of the metabolite formation demonstrated substantially improved accuracy compared to MS semi-quantitation. Moreover, the ¹⁴C calibration method offers a streamlined approach to prepare multiple metabolite standards from a single biosynthesis, reducing the time required for structure elucidation and metabolite synthesis.